News

Israel-headquartered Teva’s Azilect (rasagiline tablets) is approved for use as initial monotherapy in early Parkinson’s disease and as adjunct therapy to levodopa in moderate to advanced disease. The

The data confirm and extend earlier findings that TAT0002 enhances the function of key immune cells from HIV/AIDS donors. The results show that TAT0002 stimulates RANTES, MIP1-alpha and

Details of the newly submitted application have not been made public, but it is widely thought that the company may be seeking approval for the drug to be

La Jolla Institute for Allergy & Immunology scientist Dr Mitchell Kronenberg and an international team of scientists have identified that Borrelia burgdorferi, the bacteria that causes Lyme disease,

The Penn researchers found that IL-27 inhibits the immune system cells responsible for an array of inflammatory-related diseases, including encephalitis, arthritis, Crohn’s disease, and lupus. Their findings, which

Through a GBP7 million cash investment, Rexam, the world’s largest beverage can maker, will acquire a majority stake in a new drinks can plant, the first of its

The test will be based on the Primer and Probe Set and protocols used in a test developed by the Centers for Disease Control and Prevention (CDC) that

All of the biotechnology medicines and vaccines are now in clinical trials or awaiting approval from the FDA. They include 210 medicines to treat cancer, 50 to treat

The first new hospital buildings, in which up to half of the beds will be in single rooms, are expected to open from 2010. The go-ahead for the